Your browser doesn't support javascript.
loading
Implications of Myocardial Strain in Primary Mitral Regurgitation - A Cardiovascular Magnetic Resonance Study.
Romano, Simone; Kitkungvan, Danai; Nguyen, Duc T; El-Tallawi, Carlos; Graviss, Edward A; Farzaneh Far, Afshin; Shah, Dipan J.
Afiliação
  • Romano S; Department of Medicine, Section of Internal Medicine C, University of Verona, Verona, Italy.
  • Kitkungvan D; Houston Methodist DeBakey Heart & Vascular Center, Houston, Texas.
  • Nguyen DT; Division of Cardiovascular Medicine, McGovern Medical School, University of Texas Health Science Center at Houston, Houston, Texas.
  • El-Tallawi C; Department of Pathology and Genomic Medicine, Houston Methodist Hospital Research Institute.
  • Graviss EA; Houston Methodist DeBakey Heart & Vascular Center, Houston, Texas.
  • Farzaneh Far A; Department of Pathology and Genomic Medicine, Houston Methodist Hospital Research Institute.
  • Shah DJ; Division of Cardiology, Department of Medicine, Duke University, Durham, North Carolina.
Article em En | MEDLINE | ID: mdl-39295523
ABSTRACT

AIMS:

Chronic primary mitral regurgitation (MR) results in progressive left ventricular (LV) remodeling. Abnormal myocardial deformation (strain) can be present despite preserved ejection fraction. Cardiovascular magnetic resonance (CMR) feature-tracking techniques allow assessment of global longitudinal strain (GLS) from routine cine-images. The aim of this study was to evaluate the prognostic value of CMR feature-tracking derived GLS in patients with primary MR. METHODS AND

RESULTS:

Consecutive patients undergoing CMR for chronic MR from January 2012 to June 2018 were enrolled. Patient with LV ejection fraction <50% were excluded. The composite primary outcome aiming to detect decompensation related to MR comprised of 1) referral for mitral surgery due to symptoms or LV systolic dysfunction or 2) cardiovascular death. The secondary outcome was all-cause death. A total of 422 patients were followed for a median of 2.7 years, the primary endpoint was met in 93 patients (34 patients reported symptoms at baseline). On multivariable analysis, GLS≥ -16.6% was associated with primary outcome (hazard ratio 1.90,p=0.01). In moderate MR cohort, patient with GLS≥ -16.6% had worse event-free survival while no significant different in mild or severe MR groups. GLS≥ -16.0% remained associated with all-cause death after adjusting for other covariates including the MR severity (hazard ratio 2.24,p=0.02).

CONCLUSIONS:

In primary MR patients with preserved systolic function, GLS was associated with our composite outcomes and all-cause death. GLS may serve as a marker of cardiac dysfunction in primary MR patients with preserved systolic function allowing identification of patients likely to decompensate during observation.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Eur Heart J Cardiovasc Imaging Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Itália País de publicação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Eur Heart J Cardiovasc Imaging Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Itália País de publicação: Reino Unido